Search
Login
Register
Menu
Latest issue
Home
News
CongressUpdate
Guidelines
Specials
Links
Reimbursement News
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ Article: Nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma
“1 year subscription print edition of the Belgian Journal of Hematology (BJH)” has been added to your cart.
View cart
Article: Nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma
€
3.03
Article: Nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma quantity
Add to cart
SKU:
product-article-17993
Category:
General
Description
Description
Nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma
Related products
Article: Highlights in squamous cell carcinoma of the head and neck
€
3.03
Add to cart
Article: Highlights in melanoma
€
3.03
Add to cart
Article: INTRODUCTION
€
3.03
Add to cart
Article: Highlights in breast cancer
€
3.03
Add to cart